LOS ANGELES, July 12, 2023 (GLOBE NEWSWIRE) — Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming August 18, 2023 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired NovoCure Limited (“NovoCure” or the “Company”) NVCR…Read More
Glancy Prongay Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against NovoCure Limited NVCR NovoCure NASDAQNVCR
